Literature DB >> 9516885

Prevalence of six types of human papillomavirus in inverted papilloma and papillary transitional cell carcinoma of the bladder: an evaluation by polymerase chain reaction.

K W Chan1, K Y Wong, G Srivastava.   

Abstract

AIMS: To study the prevalence of high risk oncogenic human papillomaviruses (HPV) in inverted papilloma and papillary transitional cell carcinoma of the bladder.
METHODS: Ten cases of inverted papilloma and 20 cases of papillary transitional cell carcinoma of the bladder from Chinese patients in Hong Kong were examined for the presence of HPV type 6, 11, 16, 18, 31, and 33 genomes using the polymerase chain reaction and HPV type specific primer probe combinations on paraffin wax embedded biopsy specimens.
RESULTS: Of the 10 cases of inverted papilloma, cases 1 and 6 showed the presence of HPV types 16 and 18, respectively. Six of the 20 papillary transitional cell carcinomas were positive for HPV type 18. The other HPV types were not detected.
CONCLUSIONS: HPV type 18 was found in 60% and 30% of cases of inverted papilloma and papillary transitional cell carcinoma of the bladder, respectively. These tumours were rarely associated with HPV types 6, 11, 16, 31, and 33. The role of HPV type 18 in oncogenesis of inverted papilloma and transitional cell carcinoma of the bladder requires further studies.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9516885      PMCID: PMC500384          DOI: 10.1136/jcp.50.12.1018

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  19 in total

1.  Oncogenic association of specific human papillomavirus types with cervical neoplasia.

Authors:  A T Lorincz; G F Temple; R J Kurman; A B Jenson; W D Lancaster
Journal:  J Natl Cancer Inst       Date:  1987-10       Impact factor: 13.506

2.  Difference in prevalence of human papillomavirus genotypes in cytomorphologically normal cervical smears is associated with a history of cervical intraepithelial neoplasia.

Authors:  A J Van Den Brule; J M Walboomers; M Du Maine; P Kenemans; C J Meijer
Journal:  Int J Cancer       Date:  1991-05-30       Impact factor: 7.396

3.  p53 overexpression and human papillomavirus infection in transitional cell carcinoma of the urinary bladder: correlation with histological parameters.

Authors:  P Tenti; R Zappatore; S Romagnoli; E Civardi; P Giunta; R Scelsi; G Stella; L Carnevali
Journal:  J Pathol       Date:  1996-01       Impact factor: 7.996

4.  The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53.

Authors:  M Scheffner; B A Werness; J M Huibregtse; A J Levine; P M Howley
Journal:  Cell       Date:  1990-12-21       Impact factor: 41.582

5.  The polymerase chain reaction: a new epidemiological tool for investigating cervical human papillomavirus infection.

Authors:  L S Young; I S Bevan; M A Johnson; P I Blomfield; T Bromidge; N J Maitland; C B Woodman
Journal:  BMJ       Date:  1989-01-07

6.  Relation between infection with a subtype of HPV16 and cervical neoplasia.

Authors:  J A Tidy; K H Vousden; P J Farrell
Journal:  Lancet       Date:  1989-06-03       Impact factor: 79.321

Review 7.  p53 mutations in human cancers.

Authors:  M Hollstein; D Sidransky; B Vogelstein; C C Harris
Journal:  Science       Date:  1991-07-05       Impact factor: 47.728

8.  Detection of human papillomavirus DNA in cancer of the urinary bladder by in situ hybridisation.

Authors:  P Bryant; P Davies; D Wilson
Journal:  Br J Urol       Date:  1991-07

Review 9.  Inverted papilloma and papillary transitional cell carcinoma of urinary bladder: report of four cases of inverted papilloma, one showing papillary malignant transformation and review of the literature.

Authors:  B Lazarevic; R Garret
Journal:  Cancer       Date:  1978-10       Impact factor: 6.860

10.  Human papillomavirus associated with bladder cancer.

Authors:  Y F Shibutani; M P Schoenberg; V L Carpiniello; T R Malloy
Journal:  Urology       Date:  1992-07       Impact factor: 2.649

View more
  10 in total

Review 1.  Vaccination against human papilloma virus (HPV): epidemiological evidence of HPV in non-genital cancers.

Authors:  Ioannis N Mammas; George Sourvinos; Apostolos Zaravinos; Demetrios A Spandidos
Journal:  Pathol Oncol Res       Date:  2010-07-18       Impact factor: 3.201

2.  Detecting every genital papilloma virus infection: what does it mean?

Authors:  C P Crum
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

3.  Human papillomavirus infection and bladder cancer risk: a meta-analysis.

Authors:  Ni Li; Lin Yang; Yawei Zhang; Ping Zhao; Tongzhang Zheng; Min Dai
Journal:  J Infect Dis       Date:  2011-07-15       Impact factor: 5.226

4.  Does human papillomavirus play a role in the development of bladder transitional cell carcinoma? A comparison of PCR and immunohistochemical analysis.

Authors:  S Youshya; K Purdie; J Breuer; C Proby; M T Sheaf; R T D Oliver; S Baithun
Journal:  J Clin Pathol       Date:  2005-02       Impact factor: 3.411

5.  Role of human papillomavirus types 16, 18, and 52 in recurrent cystitis and urinary bladder cancer among Egyptian patients.

Authors:  Hala Badawi; Hanem Ahmed; Ahmed Ismail; Manal Diab; Magd Moubarak; Afkar Badawy; Mohamed Saber
Journal:  Medscape J Med       Date:  2008-10-08

6.  Coincidence of HPV11-Positive Urethral Condyloma Acuminatum and HPV-Negative Multiple Bladder Papillomas in a Female.

Authors:  Natsuko Nakazaki; Masayoshi Zaitsu; Koji Mikami; Shunsuke Yui; Ayumi Kanatani; Takushi Nakatani; Akiko Ito; Yuta Takeshima; Akiko Tonooka; Hideaki Oka; Tomoko Miki; Takumi Takeuchi
Journal:  Case Rep Med       Date:  2012-03-04

7.  Meta-analysis of studies analyzing the role of human papillomavirus in the development of bladder carcinoma.

Authors:  Antonio Jimenez-Pacheco; Manuela Exposito-Ruiz; Miguel A Arrabal-Polo; Alfonso J Lopez-Luque
Journal:  Korean J Urol       Date:  2012-04-18

Review 8.  Prevalence of Human Papilloma Virus Infection in Bladder Cancer: A Systematic Review.

Authors:  Narcisa Muresu; Biagio Di Lorenzo; Laura Saderi; Illari Sechi; Arcadia Del Rio; Andrea Piana; Giovanni Sotgiu
Journal:  Diagnostics (Basel)       Date:  2022-07-20

9.  HRAS mutations are frequent in inverted urothelial neoplasms.

Authors:  Andrew S McDaniel; Yali Zhai; Kathleen R Cho; Saravana M Dhanasekaran; Jeffrey S Montgomery; Ganesh Palapattu; Javed Siddiqui; Todd Morgan; Ajjai Alva; Alon Weizer; Cheryl T Lee; Arul M Chinnaiyan; Michael J Quist; Catherine S Grasso; Scott A Tomlins; Rohit Mehra
Journal:  Hum Pathol       Date:  2014-06-18       Impact factor: 3.466

10.  Overexpression of p16(INK4a) in urothelial carcinoma in situ is a marker for MAPK-mediated epithelial-mesenchymal transition but is not related to human papillomavirus infection.

Authors:  Julie Steinestel; Marcus V Cronauer; Johannes Müller; Andreas Al Ghazal; Peter Skowronek; Annette Arndt; Klaus Kraft; Mark Schrader; Andres J Schrader; Konrad Steinestel
Journal:  PLoS One       Date:  2013-05-28       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.